551 Health claim verifications avg. score 5.1/10 219 rated (mostly) true 266 rated (mostly) false
“Most studies reporting benefits of collagen supplements are funded by the supplement industry or by researchers with financial ties to the supplement industry.”
Industry funding is widespread in collagen supplement research, and a major 2025 meta-analysis found that positive results were concentrated in industry-funded, lower-quality trials while independent, higher-quality studies showed no significant benefit. Harvard and peer-reviewed reviews flag conflicts of interest as a pervasive concern. However, no source in the evidence base actually counts the proportion of benefit-reporting studies that are industry-funded, so the specific claim that "most" such studies meet this threshold is plausible but not directly demonstrated.
“The scientific evidence supporting the benefits of collagen supplements for non-cosmetic body systems, such as bones, joints, and digestion, is weaker or less established than the evidence for cosmetic benefits.”
This claim oversimplifies a complex evidence landscape. While digestive benefits of collagen supplements do rest on thin, mixed evidence, joint and osteoarthritis outcomes are supported by multiple reviews and meta-analyses — making them comparably or even better established than cosmetic claims. Critically, recent high-quality analyses show that positive cosmetic results are largely driven by industry-funded, lower-quality studies, with independently funded trials finding no significant skin benefits. Grouping all non-cosmetic domains as uniformly "weaker" misrepresents the actual state of the science.
“COVID-19 vaccines cause sudden death in young, healthy people.”
The claim that COVID-19 vaccines cause sudden death in young, healthy people is not supported by the evidence. Multiple large-scale population studies — including a CDC analysis, a 2026 PLOS Medicine case-control study, and surveillance data covering tens of millions of people — consistently find no increased risk of sudden death among vaccinated young individuals. While vaccine-induced fatal myocarditis has been documented in extraordinarily rare cases (28 deaths identified globally against billions of doses), this does not support the sweeping causal claim as stated.
“The SARS-CoV-2 BA.3.2 variant has significant immune escape potential and has been confirmed in 23 countries.”
CDC and WHO data confirm BA.3.2 was detected in at least 23 countries and demonstrates enhanced antibody escape in laboratory testing — both factual pillars of the claim hold up. However, describing the immune escape as "significant" without qualification overstates the real-world picture: WHO rates BA.3.2 as low additional public health risk, vaccines are still expected to protect against severe disease, and the variant shows reduced infectivity with no consistent growth advantage. The core facts are accurate, but the framing omits important context.
“ImmunityBio's drug N-803 (anktiva) is being investigated or has demonstrated efficacy in treating, curing, or preventing cancer types beyond bladder cancer.”
ImmunityBio's N-803 (Anktiva) is actively being investigated in multiple cancer types beyond bladder cancer, including pancreatic cancer, non-small cell lung cancer, glioblastoma, and other advanced solid tumors, as confirmed by ClinicalTrials.gov registrations and NCI-sponsored trials. Preliminary efficacy signals in NSCLC have been reported, though definitive Phase 3 proof of efficacy beyond bladder cancer has not yet been established. The claim's "being investigated" component is firmly supported by high-authority sources.
“Fathers are significantly more likely to be diagnosed with depression and stress-related disorders one year or more after the birth of a child than during the pregnancy period.”
This claim is grounded in a real finding from a large Swedish registry study showing a spike in fathers' clinical diagnoses at 12+ months postpartum. However, it overgeneralizes that single-country result into a broad rule. Multiple meta-analyses and systematic reviews place peak paternal depression at 3–6 months postpartum, not at one year or later. The Swedish study also compared the spike to pre-pregnancy baselines — not directly to the pregnancy period as the claim states — creating a key evidentiary gap.
“Taking caffeine before a period of sleep deprivation can fully restore social memory function that would otherwise be impaired.”
A 2026 peer-reviewed study did show caffeine reversed social memory deficits in male mice via a specific hippocampal CA2 mechanism. However, the claim's unqualified language — "fully restore social memory function" — overgeneralizes from a single animal model and one narrow social-recognition assay. No human evidence confirms this effect. Broader research shows caffeine often only partially rescues cognition under sleep deprivation and can disrupt recovery sleep. The core finding is real but the claim's framing is misleading.
“The diabetes drug metformin can suppress HIV replication, keep the virus dormant, and enable long-term remission without the need for daily antiretroviral therapy.”
This claim dramatically overstates the evidence. While metformin shows some ability to modulate HIV biology in laboratory and animal studies, no clinical evidence supports the assertion that it can enable long-term remission without daily antiretroviral therapy. Multiple peer-reviewed studies actually show metformin can increase HIV transcription and reactivate latent virus. All human studies tested metformin only as an add-on to ART, not as a replacement. The claim conflates early-stage, preclinical findings with established clinical capability.
“Holding in a sneeze can have negative health effects.”
The claim is well-supported. Multiple credible medical sources, including the Cleveland Clinic and ENT specialists, confirm that suppressing a sneeze can redirect pressure internally, potentially damaging eardrums, sinuses, throat tissue, or blood vessels. The claim uses "can have," which is a possibility statement — and documented case reports plus established physiological mechanisms are sufficient to validate it. While severe outcomes are rare, the possibility of negative health effects is real and medically recognized.
“Med beds are medically validated devices that can cure serious diseases using energy or frequency-based healing methods.”
No device called a "med bed" has been medically validated or shown to cure serious diseases in any clinical trial. The concept originates from conspiracy theories, not medical science. While some energy-based therapies (e.g., PEMF, sound stimulation) show limited benefits for specific symptoms, none constitute cures for serious diseases, and none involve "med beds." Major medical authorities, including the Cleveland Clinic and Cancer Research UK, confirm energy healing is unproven as a curative treatment. The FDA has issued warnings against unapproved medical claims for such devices.
“Waking a person who is sleepwalking can cause a heart attack or serious physical harm.”
This claim is a widely circulated myth. Major medical authorities — including the Mayo Clinic, Cleveland Clinic, Northwestern Medicine, and the American Academy of Sleep Medicine — explicitly state that waking a sleepwalker does not cause heart attacks, brain damage, or other serious medical harm. The only documented risk is temporary confusion or disorientation, which in rare cases may lead to minor accidental injury. The heart attack component is categorically unsupported by clinical evidence.
“An artificial intelligence model can detect early-stage breast cancer with approximately 94% accuracy, surpassing the average performance of radiologists.”
The claim conflates AUC/AUROC scores (~0.93) with "accuracy," which are different metrics. The best available meta-analytic evidence reports pooled AI sensitivity of 0.85 and AUC of 0.89 — not 94%. Critically, 2025 RSNA studies show AI misses approximately 14% of cancers, with false negatives concentrated in smaller, early-stage tumors in dense breasts — the very cases the claim highlights. While AI can match or modestly exceed average radiologists in some contexts, the specific "~94% accuracy for early-stage detection" framing significantly overstates the evidence.
“Metformin can keep HIV in a dormant state by blocking the DDIT4 gene.”
This claim is not supported by the available evidence. No peer-reviewed study links metformin's effects on HIV latency specifically to "blocking the DDIT4 gene." The primary literature describes metformin acting through AMPK/mTOR/mitochondrial pathways with mixed antiviral and proviral effects. Critically, DDIT4 is a negative regulator of mTORC1, so blocking it would increase mTOR activity—the opposite direction needed to promote HIV dormancy. The claim appears to stitch together unrelated biological facts into an unsupported causal chain.
“Higher cholesterol levels in the body lead to higher testosterone production.”
While cholesterol is a necessary biochemical precursor for testosterone synthesis inside cells, the claim that "higher cholesterol levels in the body" lead to higher testosterone production is not supported by human evidence. Multiple population-level studies (including NHANES data) find no association—or even an inverse relationship—between circulating cholesterol and testosterone levels. The rate-limiting step is intracellular cholesterol transport into mitochondria, not the amount of cholesterol in the bloodstream. Research also shows that low testosterone can itself raise circulating cholesterol, reversing the claimed causal direction.
“Heating olive oil produces carcinogenic compounds that pose a cancer risk to humans.”
Heating olive oil — especially past its smoke point or during prolonged, repeated frying — can generate compounds like aldehydes and PAHs that are classified as potentially carcinogenic. However, the claim is misleading because no epidemiological evidence establishes that heating olive oil poses a demonstrated cancer risk to humans under normal cooking conditions. Olive oil actually produces fewer toxic byproducts than many other cooking oils, and overall olive oil consumption is associated with reduced cancer risk in meta-analyses.
“Severe COVID-19 infection can increase the risk of faster lung cancer development.”
Multiple peer-reviewed studies and academic medical centers report an association between severe COVID-19 (hospitalization-level) and increased subsequent lung cancer incidence, supported by plausible inflammatory mechanisms. However, the claim omits critical context: the epidemiological evidence is correlational, not causal; the strongest mechanistic research involves metastatic cancer cell reactivation rather than new lung tumor formation; no major health authority has confirmed SARS-CoV-2 as a lung carcinogen; and vaccination appears to mitigate the risk. The association is real, but the causal framing is premature.
“The Apple Watch can predict heart failure with high accuracy using an AI model that analyzes peak oxygen uptake (pVO2) data.”
The claim overstates what current evidence supports. While the TRUE-HF AI model uses Apple Watch data to estimate daily fitness surrogates correlated with pVO2, the Apple Watch does not directly measure peak oxygen uptake — it estimates submaximal VO2max with known error and bias. Published findings show promising risk associations (e.g., threefold higher event risk per 10% fitness drop), but no validated "high accuracy" prediction metrics (AUC, sensitivity, specificity) for heart failure have been reported for this specific pVO2-based approach. The research is promising but preliminary.
“A newly developed drug has demonstrated the ability to reverse cognitive decline associated with Alzheimer's disease in animal models.”
The claim is accurate on its own terms. Multiple independent research groups have reported newly developed compounds — including GL-II-73, P7C3-A20, NU-9, and FLAV-27 — that reversed cognitive deficits in rodent models of Alzheimer's disease. However, the claim omits critical context: animal models are widely recognized as poor proxies for human Alzheimer's, no such reversal has been demonstrated in humans, and the history of translating preclinical AD successes to clinical benefit is marked by repeated failure.
“High sugar intake is associated with a 30% increased risk of developing depression.”
The claim overstates the evidence. A ~30–31% increased risk has been found specifically for sugar-sweetened beverage consumption, but the most comprehensive meta-analyses of overall sugar intake report a smaller association of roughly 21%. One prospective-cohort meta-analysis of total sugar found no statistically significant link at all. Presenting "30%" as the general figure for "high sugar intake" conflates a subgroup-specific finding with the broader scientific picture, and all results reflect associations, not proven causation.
“Individuals with Type 1 diabetes have nearly three times the risk of developing dementia compared to individuals without Type 1 diabetes.”
Type 1 diabetes is associated with elevated dementia risk, but "nearly three times" overstates the typical finding. The most comprehensive quantitative synthesis — a 2025 systematic review and meta-analysis — reports a pooled hazard ratio of approximately 1.50 (a 50% increase), while a large nationwide cohort study found roughly double the risk. The ~2.8× figure comes from one specific recent study and media reports echoing it, not from the broader evidence base. The claim cherry-picks the highest estimate rather than reflecting the range of peer-reviewed findings.